Targeted Drug Delivery System is a technology used to precisely deliver drugs to specific target areas. This system is designed to increase the efficacy of the drug and reduce its impact on surrounding healthy tissue. Typically, this involves using carriers or nanoparticles to encapsulate the drug so that it can be delivered more precisely to diseased tissue or target sites.
The global market for Targeted Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted Drug Delivery System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Targeted Drug Delivery System by region & country, by Type, and by Application.
The Targeted Drug Delivery System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drug Delivery System.
Market Segmentation
By Company
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
Segment by Type:
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
Segment by Application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Targeted Drug Delivery System manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Targeted Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Targeted Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Targeted Drug Delivery System Product Introduction
1.2 Global Targeted Drug Delivery System Market Size Forecast
1.3 Targeted Drug Delivery System Market Trends & Drivers
1.3.1 Targeted Drug Delivery System Industry Trends
1.3.2 Targeted Drug Delivery System Market Drivers & Opportunity
1.3.3 Targeted Drug Delivery System Market Challenges
1.3.4 Targeted Drug Delivery System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Targeted Drug Delivery System Players Revenue Ranking (2023)
2.2 Global Targeted Drug Delivery System Revenue by Company (2019-2024)
2.3 Key Companies Targeted Drug Delivery System Manufacturing Base Distribution and Headquarters
2.4 Key Companies Targeted Drug Delivery System Product Offered
2.5 Key Companies Time to Begin Mass Production of Targeted Drug Delivery System
2.6 Targeted Drug Delivery System Market Competitive Analysis
2.6.1 Targeted Drug Delivery System Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Targeted Drug Delivery System Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug Delivery System as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nano Tubes
3.1.2 Nano Wires
3.1.3 Nano Shells
3.1.4 Quantum Dots
3.1.5 Nano Pros
3.2 Global Targeted Drug Delivery System Sales Value by Type
3.2.1 Global Targeted Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Targeted Drug Delivery System Sales Value, by Type (2019-2030)
3.2.3 Global Targeted Drug Delivery System Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 First Order Targeting (Organ Compartmentalization)
4.1.2 Second Order Targeting (Cellular Targeting)
4.1.3 Third Order Targeting (Intracellular Targeting)
4.2 Global Targeted Drug Delivery System Sales Value by Application
4.2.1 Global Targeted Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Targeted Drug Delivery System Sales Value, by Application (2019-2030)
4.2.3 Global Targeted Drug Delivery System Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Targeted Drug Delivery System Sales Value by Region
5.1.1 Global Targeted Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Targeted Drug Delivery System Sales Value by Region (2019-2024)
5.1.3 Global Targeted Drug Delivery System Sales Value by Region (2025-2030)
5.1.4 Global Targeted Drug Delivery System Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Targeted Drug Delivery System Sales Value, 2019-2030
5.2.2 North America Targeted Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Targeted Drug Delivery System Sales Value, 2019-2030
5.3.2 Europe Targeted Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Targeted Drug Delivery System Sales Value, 2019-2030
5.4.2 Asia Pacific Targeted Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Targeted Drug Delivery System Sales Value, 2019-2030
5.5.2 South America Targeted Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Targeted Drug Delivery System Sales Value, 2019-2030
5.6.2 Middle East & Africa Targeted Drug Delivery System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Targeted Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Targeted Drug Delivery System Sales Value
6.3 United States
6.3.1 United States Targeted Drug Delivery System Sales Value, 2019-2030
6.3.2 United States Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Targeted Drug Delivery System Sales Value, 2019-2030
6.4.2 Europe Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Targeted Drug Delivery System Sales Value, 2019-2030
6.5.2 China Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Targeted Drug Delivery System Sales Value, 2019-2030
6.6.2 Japan Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Targeted Drug Delivery System Sales Value, 2019-2030
6.7.2 South Korea Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Targeted Drug Delivery System Sales Value, 2019-2030
6.8.2 Southeast Asia Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Targeted Drug Delivery System Sales Value, 2019-2030
6.9.2 India Targeted Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Targeted Drug Delivery System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3M Company
7.1.1 3M Company Profile
7.1.2 3M Company Main Business
7.1.3 3M Company Targeted Drug Delivery System Products, Services and Solutions
7.1.4 3M Company Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.1.5 3M Company Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Profile
7.2.2 Abbott Laboratories Main Business
7.2.3 Abbott Laboratories Targeted Drug Delivery System Products, Services and Solutions
7.2.4 Abbott Laboratories Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Laboratories Recent Developments
7.3 Ablynx NV
7.3.1 Ablynx NV Profile
7.3.2 Ablynx NV Main Business
7.3.3 Ablynx NV Targeted Drug Delivery System Products, Services and Solutions
7.3.4 Ablynx NV Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.3.5 Aciont Inc Recent Developments
7.4 Aciont Inc
7.4.1 Aciont Inc Profile
7.4.2 Aciont Inc Main Business
7.4.3 Aciont Inc Targeted Drug Delivery System Products, Services and Solutions
7.4.4 Aciont Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.4.5 Aciont Inc Recent Developments
7.5 Acrux
7.5.1 Acrux Profile
7.5.2 Acrux Main Business
7.5.3 Acrux Targeted Drug Delivery System Products, Services and Solutions
7.5.4 Acrux Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.5.5 Acrux Recent Developments
7.6 Agilis BiOthersapeutics LLC
7.6.1 Agilis BiOthersapeutics LLC Profile
7.6.2 Agilis BiOthersapeutics LLC Main Business
7.6.3 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Products, Services and Solutions
7.6.4 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.6.5 Agilis BiOthersapeutics LLC Recent Developments
7.7 Aileron Therapeutics Inc
7.7.1 Aileron Therapeutics Inc Profile
7.7.2 Aileron Therapeutics Inc Main Business
7.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Products, Services and Solutions
7.7.4 Aileron Therapeutics Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.7.5 Aileron Therapeutics Inc Recent Developments
7.8 Nano Precision Medical Inc
7.8.1 Nano Precision Medical Inc Profile
7.8.2 Nano Precision Medical Inc Main Business
7.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Products, Services and Solutions
7.8.4 Nano Precision Medical Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.8.5 Nano Precision Medical Inc Recent Developments
7.9 Novartis Pharmaceuticals Corp
7.9.1 Novartis Pharmaceuticals Corp Profile
7.9.2 Novartis Pharmaceuticals Corp Main Business
7.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Products, Services and Solutions
7.9.4 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.9.5 Novartis Pharmaceuticals Corp Recent Developments
7.10 Oxford Biomedica
7.10.1 Oxford Biomedica Profile
7.10.2 Oxford Biomedica Main Business
7.10.3 Oxford Biomedica Targeted Drug Delivery System Products, Services and Solutions
7.10.4 Oxford Biomedica Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.10.5 Oxford Biomedica Recent Developments
7.11 PharmaIN Corp
7.11.1 PharmaIN Corp Profile
7.11.2 PharmaIN Corp Main Business
7.11.3 PharmaIN Corp Targeted Drug Delivery System Products, Services and Solutions
7.11.4 PharmaIN Corp Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.11.5 PharmaIN Corp Recent Developments
7.12 PolyMicrospheres
7.12.1 PolyMicrospheres Profile
7.12.2 PolyMicrospheres Main Business
7.12.3 PolyMicrospheres Targeted Drug Delivery System Products, Services and Solutions
7.12.4 PolyMicrospheres Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.12.5 PolyMicrospheres Recent Developments
7.13 Presage Biosciences Inc
7.13.1 Presage Biosciences Inc Profile
7.13.2 Presage Biosciences Inc Main Business
7.13.3 Presage Biosciences Inc Targeted Drug Delivery System Products, Services and Solutions
7.13.4 Presage Biosciences Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.13.5 Presage Biosciences Inc Recent Developments
7.14 Pulmatrix Inc
7.14.1 Pulmatrix Inc Profile
7.14.2 Pulmatrix Inc Main Business
7.14.3 Pulmatrix Inc Targeted Drug Delivery System Products, Services and Solutions
7.14.4 Pulmatrix Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.14.5 Pulmatrix Inc Recent Developments
7.15 Quark Pharmaceuticals Inc
7.15.1 Quark Pharmaceuticals Inc Profile
7.15.2 Quark Pharmaceuticals Inc Main Business
7.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Products, Services and Solutions
7.15.4 Quark Pharmaceuticals Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.15.5 Quark Pharmaceuticals Inc Recent Developments
7.16 RegeneRx Biopharmaceuticals Inc
7.16.1 RegeneRx Biopharmaceuticals Inc Profile
7.16.2 RegeneRx Biopharmaceuticals Inc Main Business
7.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Products, Services and Solutions
7.16.4 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.16.5 RegeneRx Biopharmaceuticals Inc Recent Developments
7.17 Replicor Inc
7.17.1 Replicor Inc Profile
7.17.2 Replicor Inc Main Business
7.17.3 Replicor Inc Targeted Drug Delivery System Products, Services and Solutions
7.17.4 Replicor Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.17.5 Replicor Inc Recent Developments
7.18 Rexahn Pharmaceuticals Inc
7.18.1 Rexahn Pharmaceuticals Inc Profile
7.18.2 Rexahn Pharmaceuticals Inc Main Business
7.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Products, Services and Solutions
7.18.4 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.18.5 Rexahn Pharmaceuticals Inc Recent Developments
7.19 Roche Holding AG
7.19.1 Roche Holding AG Profile
7.19.2 Roche Holding AG Main Business
7.19.3 Roche Holding AG Targeted Drug Delivery System Products, Services and Solutions
7.19.4 Roche Holding AG Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.19.5 Roche Holding AG Recent Developments
7.20 Savara Inc
7.20.1 Savara Inc Profile
7.20.2 Savara Inc Main Business
7.20.3 Savara Inc Targeted Drug Delivery System Products, Services and Solutions
7.20.4 Savara Inc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.20.5 Savara Inc Recent Developments
7.21 Serina Therapeutics Inc.
7.21.1 Serina Therapeutics Inc. Profile
7.21.2 Serina Therapeutics Inc. Main Business
7.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Products, Services and Solutions
7.21.4 Serina Therapeutics Inc. Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.21.5 Serina Therapeutics Inc. Recent Developments
7.22 Silenseed Ltd.
7.22.1 Silenseed Ltd. Profile
7.22.2 Silenseed Ltd. Main Business
7.22.3 Silenseed Ltd. Targeted Drug Delivery System Products, Services and Solutions
7.22.4 Silenseed Ltd. Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.22.5 Silenseed Ltd. Recent Developments
7.23 SoluBest Ltd
7.23.1 SoluBest Ltd Profile
7.23.2 SoluBest Ltd Main Business
7.23.3 SoluBest Ltd Targeted Drug Delivery System Products, Services and Solutions
7.23.4 SoluBest Ltd Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.23.5 SoluBest Ltd Recent Developments
7.24 Suda Ltd
7.24.1 Suda Ltd Profile
7.24.2 Suda Ltd Main Business
7.24.3 Suda Ltd Targeted Drug Delivery System Products, Services and Solutions
7.24.4 Suda Ltd Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.24.5 Suda Ltd Recent Developments
7.25 Taiwan Liposome Co. Ltd.
7.25.1 Taiwan Liposome Co. Ltd. Profile
7.25.2 Taiwan Liposome Co. Ltd. Main Business
7.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Products, Services and Solutions
7.25.4 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.25.5 Taiwan Liposome Co. Ltd. Recent Developments
7.26 Pipeline
7.26.1 Pipeline Profile
7.26.2 Pipeline Main Business
7.26.3 Pipeline Targeted Drug Delivery System Products, Services and Solutions
7.26.4 Pipeline Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.26.5 Pipeline Recent Developments
7.27 Vect-Horus S.A.S.
7.27.1 Vect-Horus S.A.S. Profile
7.27.2 Vect-Horus S.A.S. Main Business
7.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Products, Services and Solutions
7.27.4 Vect-Horus S.A.S. Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.27.5 Vect-Horus S.A.S. Recent Developments
7.28 Vectura Group plc
7.28.1 Vectura Group plc Profile
7.28.2 Vectura Group plc Main Business
7.28.3 Vectura Group plc Targeted Drug Delivery System Products, Services and Solutions
7.28.4 Vectura Group plc Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.28.5 Vectura Group plc Recent Developments
7.29 WAVE Life Sciences Pvt. Ltd.
7.29.1 WAVE Life Sciences Pvt. Ltd. Profile
7.29.2 WAVE Life Sciences Pvt. Ltd. Main Business
7.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Products, Services and Solutions
7.29.4 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.29.5 WAVE Life Sciences Pvt. Ltd. Recent Developments
7.30 Xigen SA
7.30.1 Xigen SA Profile
7.30.2 Xigen SA Main Business
7.30.3 Xigen SA Targeted Drug Delivery System Products, Services and Solutions
7.30.4 Xigen SA Targeted Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.30.5 Xigen SA Recent Developments
8 Industry Chain Analysis
8.1 Targeted Drug Delivery System Industrial Chain
8.2 Targeted Drug Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Targeted Drug Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Targeted Drug Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
听
听
*If Applicable.
